London (Reuters)-Consumer goods giant Unilever (NYSE :) said it was approaching GlaxoSmithKline (LON :) About buying the consumer goods division of the pharmaceutical group after the newspaper reported that the £ 50 billion ($ 68.4 billion) offer was rejected.
“GSK Consumer Healthcare is an attractive consumer health leader and will be a strong strategic fit as Unilever continues to restructure its portfolio,” Unilever said in a statement on Saturday.
“I’m not sure if an agreement will be reached.”
GSK did not immediately respond to the request for comment.
Previously, The Sunday Times of the United Kingdom said that a bid for Unilever’s business was worth about £ 50 billion with GSK. Pfizer (NYSE :). I own a minority stake in this division.
He added that Unilever, which owns brands such as Dove Thorpe and Marmite, understood that Glaxo’s approach to the portfolio of household brands such as Panador painkillers and Sensodyne toothpaste was one-sided.
According to the newspaper, Unilever’s bid did not include recognition of acquisition premiums or synergies. It wasn’t clear if Unilever would make a higher offer, he added.
($ 1 = 0.7314 pounds)
Fusion media Alternatively, anyone involved with Fusion Media will not be liable for any loss or damage resulting from reliance on the data, quotes, charts, trading signals and other information contained on this website. Be fully informed about the risks and costs associated with financial market transactions. This is one of the most risky forms of investment possible.
Unilever says Reuters wants to buy GSK’s consumer goods sector
https://www.investing.com/news/stock-market-news/unilever-offers-50-billion-pounds-for-gsk-unit-report-2739800 Unilever says Reuters wants to buy GSK’s consumer goods sector